FDA Approves Novartis's Elidel
Elidel is a cream containing pimecrolimus, an immunosuppressant.
It works by decreasing your body's immune system to help slow down the growth of atopic dermatitis (eczema) on your skin.
Elidel is used to treat severe atopic dermatitis when other medications have not worked well.
Elidel is approved for the treatment of atopic dermatits in adults and children ages two years and older. This topical cream should be applied twice-daily. Elidel is the first non-steroid prescription for mild to moderate atopic dermatitis for use in children and adults and is one of the first new treatments since topical corticosteroids were introduced almost 50 years ago.
Commonly known as eczema, atopic dermatitis is an itchy skin condition affecting up to 17 percent of the US population, or more than 40 million Americans. Eczema primarily affects children and may last until the late teenage years or even for life. Ninety percent of sufferers experience symptoms before reaching the age of five.
Elidel cream is a prescription medicine used on the skin to treat eczema (atopic dermatitis), and is in a class of medicines called topical calcineurin inhibitors. This drug is for people ages 2 and older who do not have a weakened immune system. Elidel cream is used on the skin for short periods, and if needed, treatment may be repeated with breaks in between.
Elidel (pimecrolimus) is an effectual FDA endorsed prescription medication to treat mild to moderate eczema. This eczema medication is manufacturer by Novartis. Elidel medication is a steroid-free cream which is usually prescribed when other approaches to treat eczema are not suitable for you.
Elidel targets at the very site of the eczema development. The exact action of Elidel mechanism is not known, but it works by inhibiting the key cells involved in the growth of eczema. This activity in turn helps in the treatment of the symptoms of eczema.